Pages that link to "Q44642043"

The following pages link to Identification of intracellular residues in the dopamine transporter critical for regulation of transporter conformation and cocaine binding. (Q44642043):

Displaying 50 items.

• R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse (Q24621917) (← links)
• The binding sites for cocaine and dopamine in the dopamine transporter overlap (Q24650126) (← links)
• Complete mapping of substrate translocation highlights the role of LeuT N-terminal segment in regulating transport cycle (Q27320918) (← links)
• X-ray structures of LeuT in substrate-free outward-open and apo inward-open states (Q27676655) (← links)
• Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters (Q28476265) (← links)
• Molecular dynamics simulation studies of GLUT4: substrate-free and substrate-induced dynamics and ATP-mediated glucose transport inhibition (Q28476422) (← links)
• Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters (Q29616590) (← links)
• A conserved salt bridge between transmembrane segments 1 and 10 constitutes an extracellular gate in the dopamine transporter (Q30368030) (← links)
• Classic Studies on the Interaction of Cocaine and the Dopamine Transporter (Q30397145) (← links)
• Assessing the ability of sequence-based methods to provide functional insight within membrane integral proteins: a case study analyzing the neurotransmitter/Na+ symporter family (Q30481053) (← links)
• Missense dopamine transporter mutations associate with adult parkinsonism and ADHD. (Q30581669) (← links)
• An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter (Q33742741) (← links)
• Conformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocation (Q33758304) (← links)
• The substrate-driven transition to an inward-facing conformation in the functional mechanism of the dopamine transporter (Q33813126) (← links)
• Targeting of dopamine transporter to filopodia requires an outward-facing conformation of the transporter (Q33905523) (← links)
• SLC6 family transporter SNF-10 is required for protease-mediated activation of sperm motility in C. elegans (Q34052546) (← links)
• Postendocytic sorting of constitutively internalized dopamine transporter in cell lines and dopaminergic neurons. (Q34094576) (← links)
• Mutational analysis of the high-affinity zinc binding site validates a refined human dopamine transporter homology model (Q34597890) (← links)
• The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters (Q34660686) (← links)
• Site-directed mutations near transmembrane domain 1 alter conformation and function of norepinephrine and dopamine transporters (Q34701009) (← links)
• Antagonist-induced conformational changes in dopamine transporter extracellular loop two involve residues in a potential salt bridge (Q35383366) (← links)
• Dopamine transporter-dependent and -independent striatal binding of the benztropine analog JHW 007, a cocaine antagonist with low abuse liability (Q35454366) (← links)
• Mechanism of the Association between Na+ Binding and Conformations at the Intracellular Gate in Neurotransmitter:Sodium Symporters (Q35662335) (← links)
• Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants (Q36341704) (← links)
• Importance of cholesterol in dopamine transporter function (Q36453517) (← links)
• The binding sites for benztropines and dopamine in the dopamine transporter overlap. (Q36990361) (← links)
• Transition metal ion FRET uncovers K(+) regulation of a neurotransmitter/sodium symporter. (Q37315212) (← links)
• A Markov State-based Quantitative Kinetic Model of Sodium Release from the Dopamine Transporter. (Q37563730) (← links)
• Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors. (Q37709569) (← links)
• Impact of disruption of secondary binding site S2 on dopamine transporter function (Q38868543) (← links)
• An intracellular interaction network regulates conformational transitions in the dopamine transporter. (Q39142337) (← links)
• Characterization of [³H]CFT binding to the norepinephrine transporter suggests that binding of CFT and nisoxetine is not mutually exclusive. (Q39293366) (← links)
• Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells. (Q39459667) (← links)
• A juxtamembrane mutation in the N terminus of the dopamine transporter induces preference for an inward-facing conformation. (Q39903252) (← links)
• Phosphorylation of the norepinephrine transporter at threonine 258 and serine 259 is linked to protein kinase C-mediated transporter internalization. (Q40272888) (← links)
• The conserved glutamate (Glu136) in transmembrane domain 2 of the serotonin transporter is required for the conformational switch in the transport cycle. (Q40306798) (← links)
• Molecular Mechanism of Dopamine Transport by Human Dopamine Transporter (Q40415118) (← links)
• Insights into the Modulation of Dopamine Transporter Function by Amphetamine, Orphenadrine, and Cocaine Binding (Q40803358) (← links)
• The role of human dopamine transporter in NeuroAIDS. (Q41922188) (← links)
• Super-resolution microscopy reveals functional organization of dopamine transporters into cholesterol and neuronal activity-dependent nanodomains (Q42208912) (← links)
• Effects on conformational states of the rabbit sodium/glucose cotransporter through modulation of polarity and charge at glutamine 457 (Q42586128) (← links)
• The mechanism of a neurotransmitter:sodium symporter--inward release of Na+ and substrate is triggered by substrate in a second binding site (Q42909481) (← links)
• The second intracellular loop of the glycine transporter 2 contains crucial residues for glycine transport and phorbol ester-induced regulation (Q44792898) (← links)
• Zinc potentiates an uncoupled anion conductance associated with the dopamine transporter (Q45052903) (← links)
• Roles of transmembrane domain 2 and the first intracellular loop in human noradrenaline transporter function: pharmacological and SCAM analysis (Q46643994) (← links)
• Latch and trigger role for R445 in DAT transport explains molecular basis of DTDS. (Q47273983) (← links)
• Molecular dynamics of conformation-specific dopamine transporter-inhibitor complexes (Q48184197) (← links)
• Localization of cocaine analog [125I]RTI 82 irreversible binding to transmembrane domain 6 of the dopamine transporter (Q48626694) (← links)
• Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes. (Q52807144) (← links)
• Conformational dynamics of the human serotonin transporter during substrate and drug binding (Q64056398) (← links)